MUC Expression in Gallbladder Epithelial Tissues in Cholesterol-Associated Gallbladder Disease by ���������
ORiginal Article
Gut and Liver, Vol. 10, No. 5, September 2016, pp. 851-858
Background/Aims: Gallstone pathogenesis is linked to 
mucin hypersecretion and bacterial infection. Several mucin 
genes have been identified in gallbladder epithelial cells 
(GBECs). We investigated MUC expression in cholesterol-
associated gallbladder disease and evaluated the relation-
ship between mucin and bacterial infection. Methods: The 
present study involved 20 patients with cholesterol stones 
with cholecystitis, five with cholester ol stones with choles-
terolosis, six with cholesterol polyps, two with gallbladder 
cancer, and six controls. Ca nine GBECs treated with lipopoly-
saccharide were also stud ied. MUC3, MUC5AC, MUC5B, and 
MUC6 antibodies were used for dot/slot immunoblotting and 
immunohistochemical studies of the gallbladder epithelial 
tissues, canine GBECs, and bile. Reverse-transcription poly-
merase chain reaction was performed to evaluate MUC3 
and MUC5B expres sion. Results: MUC3, MUC5AC, MUC5B, 
and MUC6 were ex pressed in the normal gallbladder epithe-
lium, and of those, MUC3 and MUC5B exhibited the highest 
expression levels. Greatly increased levels of MUC3 and 
MUC5B expression were observed in the cholesterol stone 
group, and slightly increased levels were observed in the 
cholesterol polyp group; MUC3 and MUC5B mRNA was also 
upregulated in those groups. Canine GBECs treated with 
lipopolysaccharide also showed upregulation of MUC3 and 
MUC5B. Conclu sions: The mucin genes with the highest ex-
pression levels in gallbladder tissue in cholesterol-associated 
diseases were MUC3 and MUC5B. Cholesterol stones and 
gallbladder infections were associated with increased MUC3 
and MUC5B expression. (Gut Liver 2016;10:851-858)
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INTRODUCTION
Gallbladder mucin (MUC) genes are thought to be involved 
in the pathogenesis of cholesterol associated gallbladder dis-
ease.1 However, the role of MUC genes in gallstone formation 
is unclear. Of all gallstones, 80% are cholesterol gallstones, the 
formation of which is related to cholesterol supersaturation, 
nucleation of cholesterol crystals, and gallbladder hypomotility. 
Some studies have suggested that MUC genes are a contributing 
factor in cholesterol crystal nucleation.2,3 Other studies support a 
possible relationship between MUC and pigment stones, which 
are closely related to infection.4-6
Lipopolysaccharide (LPS) is a metabolic product of Escherich-
ia coli thought to be involved in MUC expression in biliary cells. 
E. coli DNA was found in all brown pigment and mixed choles-
terol gallstones.7 These findings suggest that bacterial infection 
stimulates mucin secretion from gallbladder epithelial cells,8,9 
contributing to formation of pigment stones. Bacterial infec-
tion, bile stasis, mucin hypersecretion, and changes in mucin 
characteristics such as gel-forming apomucin of the biliary tract 
contribute to gallstone formation.10 However, only a few stud-
ies have investigated MUC expression in cholesterol-associated 
gallbladder disease. Published reports differ on the MUC genes 
related to lithogenic mucin.1,5,11,12
To date, more than 20 MUC genes have been identified.13 
These genes demonstrate cell-specific expression and distribu-
tion in humans.14-22 Although reports vary slightly, it is general-
ly agreed that at least nine MUC genes (MUC1, MUC2, MUC3A, 
MUC3B, MUC4, MUC5AC, MUC5B, MUC6 and MUPCDH) are 
expressed in gallbladder and/or its associated diseases.23-29 There 
is still some disagreement about which is the principle gallblad-
der MUC. 
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A recent study demonstrated that several mucin proteins were 
overexpressed in the gallbladder especially with pigment stones 
and inflamed gallbladder.30 However, expression of various 
MUC in gallbladder with cholesterol gallstone and cholesterol 
stone-related disease still remains largely unknown. Aim of 
present study was to investigate mucin expression in normal 
human gallbladder epithelium and in gallbladder epithelial tis-
sue from patients with cholesterol gallstone diseases and also 




This study included 20 patients with histologically proven 
postoperative cholesterol stones with accompanying cholecys-
titis, five with cholesterol stone with cholesterolosis, six with 
cholesterol polyps, two with gallbladder cancer, and six normal 
controls. In vitro studies were performed using cultured dog 
gallbladder epithelial cells (DGBECs). Human bile was removed 
by surgical aspiration with a syringe. Bile was obtained after 
cleaning the gallbladder’s inner surface with phosphate buffered 
solution and was filtered before use.
Human gallbladders removed in elective surgeries for clinical-
ly-indicated reasons were used for this study. To identify cho-
lesterol stones, the external appearance and cut surface of the 
removed gallstones were inspected. Cholesterol stones are pale 
yellow with a mulberry-like appearance, and, upon sectioning, 
a crystalline radial pattern can be seen. The presence of these 
characteristics was considered sufficient for diagnosis of pure 
cholesterol stones. 
2. Experimental drugs and materials
Vitrogen (Celtrix Laboratories, Palo Alto, CA, USA) and plas-
tic tissue culture containers (Falcon, Lincoln Park, NJ, USA) 
were used. Transwell cell culture containers were 24-mm in 
diameter with 3.0-µm pore size (Costar, Cambridge, MA, USA). 
Media and cell culture solutions including Eagle’s medium es-
sential medium (EMEM), fetal bovine serum, trypsin ethylenedi-
aminetetraacetic acid (EDTA), and penicillin-streptomycin were 
from Sigma (St. Louis, MO, USA).
3. Cell culture
DGBECs were obtained as previously described.27 To obtain 
a stable cell line, 2 mL Vitrogen gel (1:1 Vitrogen: medium) 
was added to petri dishes containing trypsin-digested tissue, 
followed by 10 mL EMEM with 2 mM L-glutamine, 20 mM 
HEPES, 100 IU/mL penicillin, and 100 mg/mL streptomycin. 
The dishes were then incubated under 5% CO2 at 37
oC. Culture 
medium was changed twice weekly until the cells were mature, 
after which they were subcultured after treatment with trypsin 
(2.5 g/L) and EDTA (1 g/L). A single cell line was used after 2 to 
10 subcultures.
4. Management of LPS in DGBECs
DGBECs were treated with 100 or 200 µg/mL LPS (L2630; 
Sigma) after culturing for 6 days. According to the categorized 
groups, protein was extracted after 4, 8, or 24 hours of LPS 
treatment for 10 minutes in room temperature stripping solution 
(Pierce, Rockford, IL, USA).
5. Immunohistochemical staining of MUC3, MUC5AC, 
MUC5B, and MUC6 proteins in gallbladder epithelium
Paraffin tissue blocks were sliced into 4-µm sections and 
cleaned in running water after deparaffinization and hydration. 
After 10 minutes of blocking, 1:20 goat antihuman MUC3, MU-
C5AC, MUC5B, and MUC6 polyclonal antibodies (Santa Cruz 
Inc., Santa Cruz, CA, USA) were added for 1 hour. Biotinylated 
rabbit anti-goat IgG (DAKO, Carpinteria, CA, USA) was added 
for 20 minutes at room temperature. Streptavidin-biotin com-
plex (DAKO) was added for 20 minutes, and 3,3-diaminoben-
zidine tetrahydrochloride (DAB) was used as a coloring agent. 
Goat serum was used as the negative control. Microscopic 
examination was performed after counterstaining with Mayer’s 
hematoxylin. Immunohistochemical staining was classified as 
positive or negative based on presence.
Immunohistochemical results were independently evaluated 
by two investigators (H.S.C. and S.S.P.). The results were evalu-
ated for both percentage and intensity of stained cells. Staining 
intensity was graded as negative, weak, moderate or strong. 
When <10% of positive cells stained and/or the intensity was 0 
or 1, immunostaining was considered to be negative. 
6. Dot/slot blotting and immunodetection
Quantitation of mucin in bile, human gallbladder tissue, 
and DGBECs was accomplished by blotting onto nitrocellulose 
membranes with a Minifold II dot/slot blot apparatus (Schleicher 
& Schuell Inc., Keene, NH, USA). Membranes were air dried, 
blocked for 2 hours in 5% skim milk in Tween/Tris-buffered sa-
line (TTBS), and washed three times with TTBS. Goat antihuman 
polyclonal antibodies for MUC3, MUC5AC, MUC5B, and MUC6 
(Santa Cruz Inc.) were added at 4oC for at least 12 hours before 
washing three times with TTBS. All other samples were mixed 
with anti-goat IgG (Pierce) for 1 hour at room temperature. The 
ECL Plus Western blotting detection system (Amersham Phar-
macia, Freiburg, Germany) was utilized for detection.
7. Reverse-transcription polymerase chain reaction 
Reverse-transcription polymerase chain reaction (RT-PCR) 
was used to determine expression of MUC3 and MUC5B genes 
in gallbladder tissue and DGBECs. The primers used were as fol-
lows: MUC3 forward, 5′-TGT CAG CTC CAG ACC AGA TG-3′; 
reverse, 5′-CCT GCT CAT ACT CGC TCT CC-3′; MUC5B forward, 
5′-ATG AAA CCT GGG TCA ACA GC-3′; reverse, 5′-ATC CAC 
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GTG GGT GTA GGT GT-3′. Primers (10 mM) were combined 
with 0.1 µg/mL total RNA, 5 mM MgCl2, 10 mM dNTPs, 2.5 U 
Taq polymerase (Promega, Medison, WI, USA), and ddH2O at 
reaction volumes of 50 µL. Amplification was performed with a 
GeneAmp PCR system 9600 (Perkin Elmer, Norwalk, CT, USA) 
in the following steps: 5 minutes of denaturation at 94oC; 35 
cycles of 30 seconds at 94oC, 30 seconds at 60oC, and 2 minutes 
at 75oC; and final extension for 5 minutes at 72oC. PCR prod-
ucts were visualized on 2% agarose gels stained with ethidium 
bromide (0.5 µg/mL). Final analysis was conducted with the 
Quantity One program of a Fluor-STM Multi-Imager (Bio-Rad, 
Hercules, CA, USA).
8. Statistical analysis
ANOVA was performed for data sets containing at least three 
groups, and Student t-tests were used for comparisons between 
two data groups. Statistical significance was established at 
p<0.05.
RESULTS
1. MUC expression in normal gallbladder epithelium
Immunohistochemical staining with specific antibodies was 
positive for MUC3, MUC5AC, MUC5B, and MUC6 proteins in 
normal gallbladder epithelium. With MUC3 and MUC5B having 
the highest expression, and MUC5B being the most prominent 
(Fig. 1).
2. MUC expression in gallbladders with cholesterol stones 
Immunohistochemical staining was performed on gallbladder 
epithelium from patients with cholesterol stones and either cho-
lesterolosis or cholecystitis and compared to normal gallbladder 
epithelium. MUC3 and MUC5B were significantly overexpressed 
in the cholesterol stone group compared with the normal control 
group (Fig. 2). The presence of cholecystitis or cholesterolosis 
did not affect expression of MUC3 or MUC5B in the cholesterol 
stone group. MUC5AC was also overexpressed in the cholesterol 
stone group, although it was weak. No difference in MUC5AC 
or MUC6 expression was observed between any of these groups.
3. MUC expression in gallbladders with cholesterol polyps 
MUC3 and MUC5B were overexpressed in the gallbladder epi-
thelium of patients with cholesterol polyps compared to normal 
controls. Expression of MUC3 and MUC5B was similar between 
patients with cholesterol polyps and those with gallbladder 
cancer. Expression of MUC5AC was weakly increased in both 
cholesterol polyp and gallbladder cancer group. However, no 
significant differences were seen in the expression of MUC5AC 
or MUC6 among the cholesterol polyp, gallbladder cancer, or 
normal control groups (Fig. 3). Expression of MUC in the gall-
bladder epithelium is summarized in Table 1. The most promi-
nent overexpression of MUC3 and MUC5B was seen in gallblad-
der epithelium samples from patients with cholesterol stones.
4. Expression of MUC in bile, gallbladders with cholesterol 
stones and cholecystitis, and DGBECs with inflammation
Immunodetection by dot/slot blotting was used to compare 
inflamed gallbladder tissue, infected bile, and LPS-treated DG-
BECs with normal controls. Overexpression of MUC3, MUC5AC, 
MUC5B, and MUC6 was noted in the bile of patients with cho-
Fig. 1. Immunohistochemistry (×200) of 
a healthy gallbladder. MUC3, MUC5AC, 
MUC5B, and MUC6 were expressed in the su-
perficial epithelium and folds (arrows). MUC3 
and MUC5B were the most prominently ex-
pressed proteins. 
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Fig. 2. Immunohistochemistry (×200) in 
gallbladder tissues from patients with chole-
cystitis or cholesterolosis combined with cho-
lesterol stones. MUC3, MUC5AC, and MUC5B 
were expressed in the superficial epithelium 
and folds (arrows). The expression of MUC3 
and MUC5B was more prominent in the 
cholesterol stone groups with cholecystitis or 
cholesterolosis than in normal controls. 
Fig. 3. Immunohistochemistry (×200) in 
cholesterol polyp tissue. MUC3, MUC5AC, 
and MUC5B were expressed in the superficial 
epithelium and folds (arrows). MUC3 and 
MUC5B expression levels were slightly in-
creased in the cholesterol polyp group com-
pared to the normal controls. 
Table 1. Mucin Expression in Gallbladder Tissue as Shown by Immunohistochemistry
Histopathology Cases
Tissue
MUC3 MUC5AC MUC5B MUC6
Normal  6 + ± ++ ±
Cholecystitis with CHO stone 20 ++ ± +++ ±
Cholesterolosis with CHO stone  5 ++ ± +++ ±
Cholesterol polyp  6 ++ ± ++ ±
GB cancer  2 + ± ++ ±
CHO, cholesterol; GB, gallbladder; ±, weak; +, moderate; ++ or +++, strong.
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lecystitis compared to controls, with significant increases in 
MUC3 and MUC5B. Expression of MUC3, MUC5B, and MUC6 
in DGBECs treated with LPS was slightly higher than that in 
untreated DGBECs. Expression of MUC3 and MUC5B increased 
in bile, gallbladder tissue and DGBECs compared to that in the 
controls (Fig. 4).
5. Expression of MUC genes in gallbladder epithelium in 
gallstone diseases
RT-PCR was used to compare MUC3 and MUC5B gene ex-
pression among patients with cholecystitis secondary to choles-
terol stones and those with cholesterol polyps. Both groups had 
higher MUC3 and MUC5B gene expression than normal controls 
(Fig. 5), with highest expression seen for MUC5B.
6. Expression of MUC genes in DGBECs with LPS treatment
To evaluate changes in MUC gene expression induced by 
inflammation, 100 µg/mL or 200 µg/mL LPS was added for 4, 
8, or 24 hours in cholesterol-free conditions. In all conditions, 
MUC3 and MUC5B mRNA was significantly overexpressed 
compared to normal controls. Expression of MUC5B mRNA was 
particularly affected, with increased expression at 4 to 8 hours of 
LPS treatment followed by a decreasing trend by 24 hours (Fig. 6).
DISCUSSION
MUC3, MUC5AC, MUC5B, and MUC6 were expressed in hu-
man gallbladder epithelial cells, and MUC3 and MUC5B had the 
highest expression of these mucin genes in cholesterol associat-
ed gallbladder diseases. MUC3 and MUC5B showed a markedly 
different expression pattern in cholesterol associated gallbladder 
disease compared to normal tissue, which could indicate their 
importance in gallbladder disease pathogenesis.
For a cholesterol crystal to develop from gallbladder bile, 
at least three steps must occur: cholesterol supersaturation of 
gallbladder bile, rapid progression of nucleation, and long-term 










Fig. 4. MUC protein expression in bile, gallbladder (GB) tissue and 
canine gallbladder epithelial cells (GBECs) as shown by dot/slot blot-
ting. Bile and gallbladder tissues from patients with cholecystitis and 
cholesterol stones commonly showed increased expression of MUC3 
and MUC5B. Slightly increased levels of MUC3, MUC5B, and MUC6 
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Fig. 5. MUC gene expression in gallbladder tissues. Both MUC3 and MUC5B mRNA were upregulated in the cholecystitis with cholesterol stone (S) 
and cholesterol polyp (P) groups compared with the control group (C) (p<0.05).
Lane 1, normal control; Lanes 2 and 3, cholesterol polyp; Lanes 4 and 5, cholecystitis with cholesterol stone.
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stasis due to gallbladder hypomotility. Cholesterol supersatu-
ration is essential for, but does not always induce, gallstone 
formation. A balance between prenucleating and antinucleating 
factors in the bile allows for supersaturation without nucleation. 
Nucleation occurs when the balance between the nucleating and 
antinucleating factors is disrupted. 
Upregulation of these MUC genes could lead to the observed 
increased gallbladder mucin concentrations. Mucin may increase 
bile viscosity leading to the formation of a gel matrix that can 
entrap cholesterol crystals in the gallbladder.31 Mucin may also 
enhance cholesterol crystallization by offering low-affinity 
binding sites for cholesterol.32-34 The present study revealed a 
marked increase in MUC3 and MUC5B in the gallbladder epi-
thelium of patients with cholesterol stones with cholesterolosis 
or cholecystitis. The findings suggest that MUCs are involved in 
diseases caused by cholesterol supersaturation, consistent with 
the findings of other studies.
Lee and Liu21 analyzed differences in apomucin gene expres-
sion in gallbladder epithelium with pigment stones and normal 
gallbladder epithelium and showed that MUC1, MUC3, MUC5B, 
and MUC6 were more highly expressed in the gallbladder epi-
thelium of patients with pigment stones. Expression was signifi-
cantly reduced by 33.3% for MUC1, 83.3% for MUC3, 83.3% for 
MUC5B, and 66.7% for MUC6 in normal gallbladder epithelium 
compared to diseased tissue. In addition, expression was higher 
in the pigment stone group than in the normal control group. 
MUC2 and MUC4 were not expressed in normal gallbladder but 
did show expression rates of 20% and 60%, respectively, in the 
pigment stone group. Changes in the mucin environment are 
presumed to be involved in formation of pigment stones. Kim 
et al.35 compared MUC3, MUC5AC, and MUC6 expression in 
the gallbladder epithelium associated with both cholesterol and 
pigment gallstones and found no significant differences in MUC 
gene expression. Vilkin et al.30 demonstrated that MUC3, MU-
C5AC, MUC5B and MUC6 are expressed in the gallbladder epi-
thelium mainly with pigment stone and MUC5AC and MUC5B 
are secreted into bile. Recent study demonstrated that several 
mucin proteins were overexpressed in the gallbladder with pig-
ment stones and inflamed gallbladder.30 However, expression of 
various MUC in gallbladder with cholesterol gallstone and cho-
lesterol stone-related disease still remains largely unknown.
The increase in MUC protein expression associated with in-
fection was examined in cell culture experiments. LPS from 
E. coli increases MUC protein secretion, principally MUC2 and 
MUC5A, in mouse and dog gallbladder epithelium.1,4 We found 
that MUC3 and MUC5B expression increased in the bile and 
gallbladder epithelium of cholecystitis patients, presumed to 
be accompanied by infection. A similar result was observed in 
DGBECs with LPS-induced inflammation. We interpreted these 
results as indicating that infection or inflammatory conditions 
contribute to MUC protein expression, suggesting involvement 
in gallstone formation. In addition, we found overexpression of 
MUC3 and MUC5B in patients with cholesterol stones, regard-
less of the presence of cholesterolosis or cholecystitis. This result 
suggests that MUC secretion increases in infection or cholesterol 
supersaturation conditions and contributes to gallstone forma-
tion. 
Recent study showed that MUC5AC was overexpressed in 
gallbladder with pigment stone than one with cholesterol stone.30 
MUC5AC was also overexpressed in gallbladder with cholesterol 
stone and cholesterol polyp as well in present study but it was 
weaker than the expression of both MUC3 and MUC5B. There-
fore, we performed RT-PCR in gallbladder tissue and DGBECs 
for only MUC3 and MUC5B genes. It is still unclear whether 
expression of various MUC is different between gallstone types 
regarding conflicting results of previous studies.21,30,35 Further 
study with large sample size to compare the expression of MUC 
between various stone types would be needed in the future.
Only 10% to 15% of bile samples were positive for bacterial 
cultures, and no bacteria were isolated from surgically-removed 
cholesterol stones. To date, the demonstrated relationship be-
tween cholesterol gallstones and bacterial infection has been 
weak.36 However, 16S rRNA sequence analysis demonstrated 
that, although no bacterial DNA is present in pure cholesterol 
stones with cholesterol content greater than 90%, bacterial DNA 
is found in 70% to 90% of samples of mixed stones. E. coli were 
cultured from most of these mixed stone samples, suggesting 
involvement of bacterial infection in the formation of choles-
terol gallstones.7 Clinically, the incidence of pure cholesterol 
stones is low, and mixed stones are the predominant cause of 
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Fig. 6. MUC gene expression in dog gallbladder epithelial cells (DG-
BECs). Lipopolysaccharide-treated canine GBECs showed overexpres-
sion of both MUC3 and MUC5B mRNA compared to controls (p<0.05).
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patients for evaluating how an infection-induced inflammatory 
condition affects MUC gene and protein expression formation 
are inherently limited. For this reason, we used cultured DGBECs 
treated with LPS to measure MUC3 and MUC5B gene expression 
using RT-PCR. A significant increase in the expression of MUC3 
and MUC5B mRNA was observed, suggesting that infection-
induced inflammation is essential for MUC expression.
Present study showed a unique pattern of various MUC ex-
pression regarding conflicting results of previous studies.21,30,35 
All gallbladder specimens of present study obtained from cho-
lesterol associated gallbladder diseases. The expression pattern 
of various MUCs may be different between gallstone types, 
however it still remains unclear. Additionally, the mechanism of 
overexpression- of various MUCs might be different in gallstone 
disease. Previous study suggested that MUC5AC mRNA and 
protein production was significantly increased in gallblad der 
with cholesterol stones by EGF-R ligands (either EGF or trans-
forming growth factor-α) in the presence of TNF-α, whereas 
expression of the other gallbladder mucins MUC1, MUC3, and 
MUC5B was unchanged.38 The pattern of expression of mucin 
core proteins in gallbladder epithelium with cholecystitis also 
may be altered with increasing degrees of inflammation. Ho et 
al.25 showed that MUC5AC was most significantly decreased in 
gallbladder specimens with acute inflammation compared with 
MUC5B. The relative functional roles of each of these individual 
mucin glycoproteins in mucosal cytoprotection and gallstone 
formation remain to be determined.
The expression of MUC3 and MUC5B increased slightly in 
patients with cholesterol polyps and gallbladder cancer; expres-
sion of other MUCS was negligible. However, since the study 
population was small with no stage categorization, additional 
studies focusing on MUC as a prognostic factor in neoplastic 
diseases of the gallbladder are needed. 
In conclusion, MUC3, MUC5AC, MUC5B, and MUC6 were 
expressed in the normal gallbladder epithelium, with MUC3 and 
MUC5B being the most highly expressed. Diseases associated 
with cholesterol supersaturation, such as cholesterol stones and 
cholesterolosis, and infection induced by inflammation within 
the gallbladder were associated with overexpression of MUC3 
and MUC5B. These events were presumed to be closely related 
to gallstone formation. In future studies, the relationship be-
tween cytokines and inflammation related to MUC expression 
should be explored, in addition to the mechanism that controls 
MUC expression.
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